Delivery Order SPE2DB20D2104-SPE2DB20FR09U
- Not listed
- This federal contract award is for a prime vendor pharmaceutical distribution contract between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,140.97, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,646.35, was awarded by the Defense Logistics Agency (DLA) and covers the delivery of a wide range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare...
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $34,479.79, provides a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,738.78 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on a firm-fixed-price basis. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of medical products and supplies to support military healthcare programs and other federal agencies. The contract, valued at $1,217.58, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of pharmaceutical and medical supplies to the U.S. Department of Defense (DoD) and other federal agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,977.84, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $82,582.15, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver essential...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of medical commodities to the U.S. government. The contract, valued at $2,304.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer for Amerisourcebergen. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,532.82, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award is for a prime vendor pharmaceutical distribution contract, valued at $1,139.24, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This is an open competition contract, with no set-aside designation....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FR09UDelivery Order
This federal contract award is for a prime vendor pharmaceutical distribution contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,711.16, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for providing these critical medical commodities across multiple therapeutic areas. This IDC encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/10/20 |